Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Phase III Trial to Investigate the Efficacy of Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.

NCT03749590 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT03749590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03749590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Phase III Trial to Investigate the Efficacy of Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.
Lead sponsor
University Medicine Greifswald
Phase
Phase 3
Overall status
Terminated
Start date
August 27, 2012
Completion date
August 31, 2020
Enrollment
327 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis